High levels of circulating osteopontin in inflammatory lung disease regardless of Sars‐CoV‐2 infection

Mostrar otras versiones (1)

This study independently confirms increased levels of osteopontin in COVID‐19 patients but also suggests that osteopontin cannot be used as a biomarker of SARS‐CoV‐2 infection, as elevated levels of circulating osteopontin are found in inflammatory lung disease regardless of SARS‐CoV‐2 infection.[Im...

Descripción completa

Detalles Bibliográficos
Autores principales: Cappellano, Giuseppe, Abreu, Hugo, Raineri, Davide, Scotti, Lorenza, Castello, Luigi, Vaschetto, Rosanna, Chiocchetti, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103078/
https://www.ncbi.nlm.nih.gov/pubmed/33787012
http://dx.doi.org/10.15252/emmm.202114124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103078/
https://www.ncbi.nlm.nih.gov/pubmed/33787012
http://dx.doi.org/10.15252/emmm.202114124

Ejemplares similares